BioPharm News

Oct 25, 2017
By BioPharm International Editors
Catalent’s new Biologics & Specialty Drug Delivery unit will be led by Barry Littlejohn; Jonathan Arnold to lead Oral Drug Delivery.
Oct 24, 2017
By BioPharm International Editors
The API manufacturer has announced that it has completed the expansion of large-scale manufacturing capabilities at its Charles City, Iowa site.
Oct 24, 2017
By BioPharm International Editors
The biopharmaceutical company has received a $4.2-million grant from the Bill & Melinda Gates Foundation to invest in the development of new treatments for Enterotoxigenic Escherichia coli infections, a bacterial cause of diarrhea in the developing world.
Oct 24, 2017
By BioPharm International Editors
The agency has published educational material for physicians promoting the benefits of biosimilars.
Oct 24, 2017
By BioPharm International Editors
How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?
Oct 24, 2017
By BioPharm International Editors
Girish Malhorta, CPhI expert and president of EPCOT International, discussed world revenues for pharmaceuticals and how companies may improve cost and availability of drugs in CPhI’s 2017 Annual Report.
Oct 23, 2017
By BioPharm International Editors
The biotechnology company has officially opened its new Michigan research and production center for the production of spider silk-based fibers, as well as for the company’s polymer research and development program.
Oct 23, 2017
By BioPharm International Editors
The clinical-stage biopharmaceutical company has announced the opening of a new gene therapy manufacturing facility in Modiin, Israel, which is anticipated to be the production site of the company’s lead cancer drug candidate.
Oct 23, 2017
By BioPharm International Editors
The $72-million investment, part of a larger $850-million investment into its US operations, will allow the drugmaker to replace an outdated insulin vial-filling line and to upgrade technology at its Indianapolis manufacturing plant.
Oct 23, 2017
By BioPharm International Editors
The company is recalling several injectable products because of possible microbial contamination.
native1_300x100
lorem ipsum